References
- Avruch J (2007). MAP kinase pathways: the first twenty years. Biochim Biophys Acta, 1773, 1150-60. https://doi.org/10.1016/j.bbamcr.2006.11.006
- Bustamante J Picard C, Fieschi C (2007). A novel X-linked recessive form of Mendelian susceptibility to mycobaterial disease. J Med Genet, 44, 65.
-
Chen B, Sun Q, Wang X, et al (2008). Reversal in multidrug resistance by magnetic nanoparticle of
$Fe_{3}O_{4}$ oaded with adriamycin and tetrandrine in K562/A02 leukemic cells. Int J Nanomed, 3, 277-286. - Chen SY, Hu SS, Dong Q, et al (2013). Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo. Asian Pac J Cancer Prev, 14, 6135-40. https://doi.org/10.7314/APJCP.2013.14.10.6135
- Chow KC, Tang CN, Lai ECh, et al (2013). Curative treatment for recurrent tumour implantation after ruptured hepatocellular carcinoma. Hong Kong Med J, 19, 82-84.
- Chen SF, Nieh S, Jao SW, et al (2012). Quercetin Suppresses Drug-Resistant Spheres via the p38 MAPK-Hsp27 Apoptotic Pathway in Oral Cancer Cells. PLOS ONE, 7, 111-9.
- Claessens YE, Bouscary D, Dupont JM, et al (2002). In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis. Blood, 99, 1594-601. https://doi.org/10.1182/blood.V99.5.1594
- Fang JY and Richardson BC (2005). The MAPK signalling pathways and colorectal cancer. Lancet Oncol, 6, 322-7. https://doi.org/10.1016/S1470-2045(05)70168-6
- Korhonen L, Belluardo N, Mudo G, Lindholm D (2003). Increase in Bcl-2 phosphorylation and reduced levels of BH3-only Bcl-2 family proteins in kainic acid-mediated neuronal death in the rat brain. Eur J Neurosci, 18, 1121-34. https://doi.org/10.1046/j.1460-9568.2003.02826.x
- Li Y, Li S, Han Y, et al (2008). Calebin-A induces apoptosis and modulates MAPK family activity in drug resistant human gastric cancer cells. Eur J Pharmacol, 591, 252-8. https://doi.org/10.1016/j.ejphar.2008.06.065
- Nishimoto S and Nishida E (2006). MAPK signalling: ERK5 versus ERK1/2. EMBO reports, 8, 782-6.
- Ozdemir S, Uludag A, Silan F, et al (2013). Possible roles of the xenobiotic transporter P-glycoproteins encoded by the MDR1 3435 C>T gene polymorphism in differentiated thyroid cancers. Asian Pac J Cancer Prev, 14, 3213-7. https://doi.org/10.7314/APJCP.2013.14.5.3213
- Perez-Tomas R (2006). Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr Med Chem, 13, 1859-76. https://doi.org/10.2174/092986706777585077
- Ren YQ, Han JQ, Cao JB, et al (2012). Association of MDR1 gene polymorphisms with susceptibility to hepatocellular carcinoma in the Chinese population. Asian Pac J Cancer Prev, 13, 5451-4. https://doi.org/10.7314/APJCP.2012.13.11.5451
- Roy M and Mukherjee S (2014). Reversal of resistance towards cisplatin by curcumin in cervical cancer cells. Asian Pac J Cancer Prev, 15, 1403-10. https://doi.org/10.7314/APJCP.2014.15.3.1403
- Wakamatsu T, Nakahashi Y, Hachimine D, et al (2007). The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins. Int J Oncol, 31, 1465-72.
- Yan F, Jiang Y, Li YM, et al (2008). Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 Isomers, tetrataisohydroquinolin derivatives. Biol Pharm Bull, 31, 1258-64. https://doi.org/10.1248/bpb.31.1258
- Yan F, Wang XM, Pan C, et al (2009). Down-regulation of extracellular signal-regulated kinase 1/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells. World J Gastroenterol, 15, 1443-51. https://doi.org/10.3748/wjg.15.1443
- Zhu CY1, Lv YP, Yan DF, et al (2013). Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells. Asian Pac J Cancer Prev. 14, 6757-60. https://doi.org/10.7314/APJCP.2013.14.11.6757
Cited by
- Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs vol.35, pp.5, 2016, https://doi.org/10.3892/or.2016.4622
- Mda-7/IL-24 induces the differentiation of B cell lymphoma via activation of the P38 mitogen activated protein kinase signaling pathway vol.16, pp.4, 2017, https://doi.org/10.3892/mmr.2017.7306
- Vanadium complex: an appropriate candidate for killing hepatocellular carcinoma cancerous cells pp.1572-8773, 2018, https://doi.org/10.1007/s10534-018-0139-x